health · digital
game over after module one
New Zealand made a trial-tested depression game free without referral: about 2% of 12–19-year-olds registered over seven years, and 3.1% of those who started it finished all seven modules in the site's logs, against a self-reported 60% in the original trial
Source: Fleming et al., “Nationwide Implementation of Unguided Cognitive Behavioral…” Open ↗source: primaryLast updated: 2026-11-12
Problem statement
SPARX is a seven-module self-help cognitive behavioural therapy programme for adolescent depression delivered as a fantasy "serious game": the player takes on challenges to "restore the balance" in a game world while a virtual guide introduces and reviews CBT skills at the start and end of each module. In a 2012 non-inferiority randomised trial with 187 help-seeking adolescents in New Zealand primary care it did at least as well as usual care, and 60% of the 80 (of 94 allocated to it) who returned questionnaires reported completing all seven modules. In 2014 New Zealand's Ministry of Health made it free, without referral, to anyone with a New Zealand internet address. Over its first seven years, about 21,300 people aged 12–19 registered (the paper gives 21,320 in its abstract and 21,310 in its results) — about 2% of that age group — and 13,564 started it. Of those who started, the site's automatically collected analytics show that 51.1% finished module 1, 7.4% finished at least four modules and 3.1% (416 young people) finished all seven. Those who kept going showed symptom improvement the authors call consistent with the trial (effect size 0.51 among the 473 with scores at modules 1 and 7), though without a comparison group. A smartphone-app version tested in a 134-school Australian trial (delivered in the 71 intervention schools) also had low engagement: 22% completed at least four of seven modules, and the trial found no effect on depression at 12 months. The unsolved problem is a game-delivered therapy that adolescents keep playing when no one prescribes it, reminds them in person or checks on them — the conditions of a free national service rather than a trial.
Why this matters
The paper reports that over 20% of New Zealand secondary-school students reported clinically significant depressive symptoms in 2019, and that 50–80% of young people with symptoms do not get treatment; the authors conclude that, given these barriers, free and private access to evidence-based digital therapy is essential, and that programmes freely available to large numbers of users around the clock are critical components of a mental health system. The same drop-off is general in the field: the authors cite a review of seven self-help interventions implemented in real-world settings that found much lower retention than in trials of the same programmes, internet-traffic data showing median retention in public mental-health apps under a quarter of trial retention, and MoodGYM, where 0.5% of public users completed a final assessment against 22.5% in a trial. Reviews of gaming interventions find benefit on average — a 2022 meta-analysis of seven randomised trials in 12- to 25-year-olds found an effect on depression (g = −0.54) though not on anxiety, and later reviews (2024, 2025) report small-to-moderate effects — but individual SPARX trials have been null (a Dutch classroom trial, an Irish trial of SPARX-R), and a large 2025 school cluster trial (6,388 students) found no effect at scale alongside low engagement. Its authors point to engagement and delivery, not only content, as what broke down; the brief takes engagement under public conditions as the problem, not a settled question about efficacy.
What’s been tried and why it hasn’t worked
The national rollout (2014–2021). The research team adapted the CD-ROM version from the trial for web delivery, added an in-game depression questionnaire at modules 1, 4 and 7, help-seeking prompts, a free phone, text and (from 2017) web-chat backup run by a counselling partner, printable module summaries, opt-in email reminders at 2 and 4 weeks after last use, promotion to health and school staff, and social-media advertising. The paper documents why some registrants could not begin: for the first years SPARX ran only on desktop or laptop computers, users had to download a large file that some firewalls blocked or slow connections could not handle, changes to browsers and the Unity game player meant only some browsers worked at some times, and the 2018 mobile version was still laid out for computers and hard to read and use on a phone. Engagement problems the authors name beyond logistics: the game interface (moving characters, too few save points), and that "users accustomed to high-budget, rapidly evolving commercial games may have been disappointed." Use also diverged from design: 46.7% of starters who filled in the first questionnaire had moderately severe or severe symptoms (the programme targets mild to moderate), and most moved through modules faster than the advised one or two a week. Māori, female, younger and school-referred young people made up a smaller share of starters than of registrants. Elsewhere. The paper's literature review reports that a Dutch version of SPARX was not more effective than monitoring or group CBT in a classroom randomised trial, and that a revised version was not successfully implemented in a youth-justice programme, where few tried it. A phone app in schools (2019–2022). The Future Proofing Study, a cluster randomised trial by a different team, put an app version of SPARX on the smartphones of 3,266 Year 8 students (13–14 years) in 71 Australian schools (6,388 students in 134 schools in all), with schools told to give at least four 20-minute class sessions. Many schools did not, citing time pressure and school limits on phones in class, and told students to do it in their own time instead. 43% never engaged and 22% completed at least four of seven modules, against 59% in the team's earlier school trial where class time was scheduled and checked; at 12 months there was no difference in depression between arms. The authors name the programme's look and feel, "developed >10 years ago, with now-dated graphics and gaming features" (one student: "I could be playing way better games"), that only about half found it useful or easy to understand, the young age of the sample and the COVID-19 period as possible reasons. This was universal prevention, not help-seeking adolescents, so it tests delivery more than treatment. Guided delivery. Fleming et al. note that guided or blended delivery usually (not always) improves retention but costs more and may put off adolescents who want anonymous help; a pilot randomised trial in England (SPARX-UK) compared e-coach-supported with self-directed SPARX on adherence; its registry record (ISRCTN15124804, last updated 7 August 2025) shows recruitment ended in March 2025 with 126 enrolled and the trial ended in June 2025, the only papers it lists are the trial protocol and a process-evaluation protocol, and no outcome results were found in November 2026.
What would unlock progress
The developers' own list: better onboarding and user experience, regular technical updates, "adaptive, user-centered approaches" that fit the programme to how adolescents actually use it (most moved through it faster than advised), single-session or "micro" formats, chatbot or text support, personalisation and cultural responsiveness, persuasive design and co-design. The game format is a specific lever: the authors suggest that presenting SPARX as a game may have raised its appeal for some adolescents, while users accustomed to high-budget commercial games may have been disappointed. An updated SPARX 2.0 with enhanced graphics, gameplay and a mobile-optimised design has been released (the paper gives both October 2021 and 2023 for this in different passages) and the authors say its data will be reported later; at the time of this brief no engagement data for it were found. A phone app on its own has also been tried: in the Future Proofing trial the app version still lost most users once no class time was set aside. So the brief starts from what those attempts left unsolved: which game-design changes move the drop-off in and just after module 1 when no one schedules the sessions — 48.9% of starters did not finish module 1, and only 41% of those who did went on to finish module 2 (20.9% of all starters).
How we’d know it’s being solved
Funnel measures from a public deployment, not a trial: registration-to-start conversion, completion of module 1, of module 4 and of all modules, and time between modules, broken down by group (including Māori and Pacific adolescents, whom the authors single out for equity). A clinically meaningful outcome alongside them, ideally with a comparison condition, since in the rollout data symptom change is correlational and mean scores at module 7 remained above the clinical cut-off. Beware the proxy: registrations measure interest, not treatment received.
Where to start
Facility-free door: using the paper's published module structure and drop-off funnel, design and prototype an alternative onboarding and module-1 experience for a CBT serious game (shorter first session, more save points, phone-first controls, a clear "what you get from module 2" hook), and run usability and intention-to-continue tests with young adult volunteers who are not in treatment. The paper describes free access to SPARX as open to anyone with a New Zealand internet address, so teams outside New Zealand should plan to work from the published descriptions and from openly available serious games, not SPARX. Analysis door: build a comparative teardown of engagement mechanics in commercial mobile games popular with 12–19-year-olds versus published mental-health serious games (save systems, session length, progression feedback), producing design requirements grounded in the specific failure points the SPARX paper reports. Partner door (design the trial, don't run it): with a digital mental-health provider, write a protocol for a micro-randomised or A/B trial of re-engagement prompts and onboarding variants inside a live service, with module-2 start as the primary outcome, safeguarding procedures for high-severity users, and a pre-registered analysis plan. Access note: any study with adolescents with depressive symptoms needs ethics review and a clinical safety plan; the first two doors involve none. Relevant skills: game design, UX research, clinical psychology, data science, cultural co-design.
Genes
Related problems
Stuck the same way, in other fields.
field: water & energyclean heat wants cooler pipesDistrict heating is about 90% fossil, and few networks run at the low temperatures that suit clean heat sourcestested in the wrong worldsource: secondaryfield: digital & spaceseven mirrors that must bend as oneExtremely large telescopes depend on adaptive optics, the largest technical concern flagged for the US telescope programtested in the wrong worldsource: primaryfield: food & the living worldharvested, then lostSmallholder farmers in developing countries lose up to 15% of income to preventable food spoilagetested in the wrong worldsource: secondaryfield: food & the living worldone pallet, three different temperaturesCold chain last-mile: 3.5x temperature risk differential within single palletstested in the wrong worldsource: primarySources
- Fleming T, Lucassen M, Frampton C, Parag V, Bullen C, Merry S, Shepherd M, Stasiak K. "Nationwide Implementation of Unguided Cognitive Behavioral Therapy for Adolescent Depression: Observational Study of SPARX." Journal of Medical Internet Research 27:e66047, 2025, doi:10.2196/66047, accessed 2026-10-22. Link ↗
- Townsend C, Humpston C, Rogers J, Goodyear V, Lavis A, Michail M. "The effectiveness of gaming interventions for depression and anxiety in young people: systematic review and meta-analysis." BJPsych Open 8(1):e25, 2022, doi:10.1192/bjo.2021.1078, accessed 2026-10-22. Link ↗
- Gómez-León MI. "Serious games to support emotional regulation strategies in educational intervention programs with children and adolescents. Systematic review and meta-analysis." Heliyon 11(4):e42712, 2025, doi:10.1016/j.heliyon.2025.e42712, accessed 2026-10-22. Link ↗
- Eve Z, Turner M, Di Basilio D, et al. "Therapeutic games to reduce anxiety and depression in young people: A systematic review and exploratory meta-analysis of their use and effectiveness." Clinical Psychology & Psychotherapy 31(1):e2938, 2024, doi:10.1002/cpp.2938 (full text read 2026-11-12 from the publisher PDF), accessed 2026-10-22. Link ↗
- SPARX, official site, accessed 2026-10-22. Link ↗
- Werner-Seidler A, Mackinnon A, Batterham PJ, et al. "Future Proofing Study: a cluster randomised controlled trial evaluating the effectiveness of a universal school-based cognitive-behavioural programme for adolescent depression." BMJ Mental Health 28(1):e301426, 2025, doi:10.1136/bmjment-2024-301426, accessed 2026-10-22. Link ↗
- Khan K, Hall CL, Babbage C, et al. "Precision computerised cognitive behavioural therapy (cCBT) for adolescents with depression: a pilot and feasibility randomised controlled trial protocol for SPARX-UK." Pilot and Feasibility Studies 10(1):53, 2024, doi:10.1186/s40814-024-01475-7 (abstract read via Europe PMC record), accessed 2026-10-22. Link ↗
- ISRCTN registry, record ISRCTN15124804 (SPARX-UK; record last updated 2025-08-07), accessed 2026-11-12. Link ↗ Link 2 ↗
Also cited in the brief
- The 2012 BMJ trial itself (Merry et al.) (publisher PDF) Link ↗
Revision notes
This brief gets checked against its sources and contains the following revisions. Future revisions get added here.
Worth knowing
- the English pilot trial comparing coach-supported with self-directed SPARX has ended but has not reported its results
Full check
Sources read
- Fleming et al., SPARX national rollout in New Zealand (JMIR, 2025): full text
- Werner-Seidler et al., Future Proofing Study school trial (BMJ Mental Health, 2025): full text
- Merry et al., original SPARX trial (BMJ, 2012): full text
- Townsend et al., meta-analysis of serious games for depression (BJPsych Open, 2022): full text
- Gómez-León, review of serious games for anxiety and depression (Heliyon, 2025): full text
- Eve et al., meta-analysis of therapeutic games (Clinical Psychology & Psychotherapy, 2024): full text
- SPARX-UK pilot trial registry record: full text
- SPARX website: full text (home page and the game, support, about, professionals and terms pages)
- Khan et al., SPARX-UK pilot trial protocol (Pilot and Feasibility Studies, 2024): abstract only
- de Rooij et al., review of design processes in serious games for adolescent mental health (JMIR Serious Games, 2026): abstract only
What changed
- Not found in the sources, replaced with what they say: that SPARX can be played only from a New Zealand internet address; the paper says free access is open to anyone with one, and the starting point now says that.
- Stated more strongly than the source: the download and access problems were said to explain why many registrants never got going; the paper says some registrants could not begin.
- Contradicted by the source, corrected: the Australian app trial was said to do no better on engagement than the rollout; on the papers' figures its engagement was higher (22% against 7.4% finishing four modules), though still low, and the page now says it also had low engagement.
- Numbers: the 46.7% with severe symptoms is a share of starters who filled in the first questionnaire, not of all starters.
- Other: the source notes called one review paywalled; it is open access.
Left open
- the Dutch classroom trial and the youth-justice study results (as the rollout paper reports them; neither study was read)
Separate check of specific claims: The English pilot trial's registry record was added: it enrolled 126 and has ended, and the only papers it lists are protocols.
Separate check of specific claims: The full title now says the original trial's 60% was self-reported while the rollout's 3.1% comes from the site's logs (display title unchanged), and a review's details were completed.
Earlier full check: Five statements were brought in line with the sources, including how many schools received the app, the authors' own conclusion about free digital therapy, and an unsupported 'largest trial' claim.
Separate check of specific claims: The full title no longer says the game was free to every teenager, a registrant count and a drop-off figure were corrected, and a large Australian app trial with no effect on depression was added.